• Home
  • Site Map
  • Contact Us

Alpha-1 Antitrypsin Deficiency Support
facebook
twitter
email

  • About Us
    • About Alpha-1 Awareness
    • Our Booklets
    • Facebook – Our Group
    • Helping Research
    • Newsletters
      • Subscribe to our Newsletters
      • Old Newsletters
    • Alpha1 Scotland
  • Alpha-1
    • Diagnosis
      • Understanding A1AT/AATD
      • Who Should be tested?
      • Videos explaining the condition
    • Treatment
      • Treatment & Therapies
        • Inhalers
        • Nebulisers
        • Antibiotics
        • Healthy Eating
        • Lifestyle
        • Pulmonary Rehabilitation
        • Replacement Therapy
        • Surgical Options
      • Quality Standard of Care
      • Expert Recommendations
  • Children
    • Children with Alpha-1
    • Guide for Schools
    • Alphie Kids Club
  • Info
    • Glossary
    • Links
    • Neswletters
      • Subscribe to our Newsletters
      • Old Newsletters
    • Our Booklets
    • Useful Information
      • Natural Cleaning Products you can make for your home
  • Support Us
    • Car Stickers
    • Collection Boxes, Buckets & Tins
      • Request a Collection Box, Bucket or Tin
      • How to send us the money you have collected
        • Collection Box
        • Collection Bucket
        • Collection Tin
    • How to send us donations
    • Just Giving
      • How to setup a page
      • Just Giving Leader board
    • Fundraising Information
    • Completed Fundraising Events
      • 2018
        • James Balson – 7th April 2018 – Prague Half Marathon
        • Louise Balson – 7th April 2018 – Prague Half Marathon
        • Stephanie Kimble – 15th March 2018 – Milton Keynes Festival of Running 5K
        • Gemma Vivian – 22nd April 2018 – The London Marathon
        • Andrew Stringer – 20th May 2018 – Richmind Marathon
        • Cai Bull – Headshave – July 2018
        • British 10K Run – July 2018
        • Alistair Jagger – 13th July 2018 – London to Paris of bike
        • TrekFest (The Peaks) – September 2018
        • John Gareth Trainor – September 2018 – Cycling the Pyrenees (all of them!)
        • Helen Moss – 27th October 2018 – Eastbourne Beachy Head 10K
      • 2017
        • Paul Amos – 14th May 2017 – Tandem Skydive
        • Cori Ruktanonchai ~ 3rd June 2017 – Stockholm Marathon
        • Paul Seager – 17th June 2017 – 45 Fell Walk
        • British 10K Run – 9th July 2017
        • Sharon Simpson – 2nd September 2017 – 25k Trek Fest (Peak District)
        • Matt Rowley – Runner
        • James Balson – 15th October 2017 – Amsterdam Half Marathon
        • Katie Rigby – 28th October 2017 – Kernow Destroyer
  • Shopping
  • Contact Us



Diagnosis – Understanding Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency (A1AT) is a genetic defect on chromosome 14 that causes the liver either not to produce the protein called alpha-1 antitrypsin (AAT) or to produce this substance with errors in the structure of its molecules. These badly formed molecules fold incorrectly and are largely unable to leave the liver.

In contrast to the rest of the body, the problem in the liver is not a lack of but rather an accumulation of abnormally folded protein in the liver cells, and this damages them. In turn, the damaged cells can lead to prolonged jaundice in the new-born or bile stasis or chronic liver disease in children. Affected children often have poor appetite and fail to thrive. Although 10 to 20% of children with alpha-1 antitrypsin deficiency have liver involvement, that figure drops to 2 to 5% with increasing age. However, there are Alpha-1 patients who do not develop any symptoms until adult age. They are then more likely to develop cirrhosis (scarring) or cancer of the liver. As yet there is no specific drug treatment for liver alphas.

We inhale and exhale approximately 0.5 litres of air with every breath. This equates to between six and eight litres of air circulated per minute, or around 10,000 litres a day. We also draw exhaust gases, dust, cigarette smoke (actively and passively), pollen, bacteria and much more into our lungs with every breath. The lungs defend themselves against these irritants with a substance (an enzyme) which is secreted by white blood cells and which keeps our lungs clean. Alpha-1 antitrypsin serves to stop this substance from attacking healthy lung tissue. If it is absent or in short supply, this protective function is insufficiently carried out, resulting in damage in the form of pulmonary emphysema, where the tiny air sacs are destroyed. The walls between the air sacs fuse, the lung tissue loses its elasticity and large cavities form and these fill with residual air. Shortness of breath develops – first during physical exertion, but in the advanced stage even at rest. Pulmonary emphysema is irreversible, i.e. the destruction of healthy lung tissue cannot be made good again. This process cannot as yet be halted, but it can be significantly slowed down by supplying alpha-1 antitrypsin in the form of weekly infusions (augmentation therapy).

In rare cases alpha-1 antitrypsin deficiency also damages other organs such as the skin (panniculitis or the inflammation of subcutaneous fatty tissue), the pancreas and blood vessels (vasculitis).

For a more technical explanation, including details of the damage that can occur to the liver, we recommend the following websites.

  • alpha-1 according to Net Doctor
  • alpha-1 according to Wikipedia
 

Additional Information

  • Liver

    People with the Pi Z gene produce a slightly different form of alpha-1 antitrypsin protein in their liver which becomes trapped and can cause irreversible liver damage. Several different types of liver conditions can be associated with alpha-1 antitrypsin deficiency. These are explained in more detail in our Alpha-1 Antitrypsin Deficiency Information – The Liver (83Kb PDF). If you have a child with liver problems then you may find our Alpha-1 Children page useful.
  • Panniculitis

    Panniculitis is an inflammation of the fatty tissue layer that lies underneath the outermost or superficial layers of our skin. Sometimes panniculitis is caused by alpha-1 antitrypsin deficiency.

    Various therapies have been tried and evaluated for the treatment of panniculitis. These include corticosteroids antibiotics (doxycycline and dapsone), full plasma exchange and augmentation therapy. Of these various treatments, augmentation therapy has been the most dramatically successful. Several reports describe resolution of panniculitis after as few as 3 doses of intravenous augmentation therapy. The dose of augmentation therapy for panniculitis is the same as that for established emphysema, 60 mg/kg once weekly.

    More details about the condition can be found on the Publications page. If you wish to know more, Contact Us and we will try to help.

Diagnosis of A1AT/AATD

  • Understanding A1AT/AATD
  • COPD Severity

Search Our Website



  • Home Page
  • About Us
  • Helping Research
  • Shopping
  • Regional
  • Understanding AATD
  • Children with Alpha-1
  • Treatment/Therapies
  • Glossary
  • Latest News
  • Links
  • Our Booklets
  • Contact Us

Reg. Charity England and Wales: 1125467, Scotland: SC041100
© 2020 Alpha-1 Awareness
KHS DataSys